Standard BioTools (LAB) Financial Statements & Analysis

Standard BioTools (LAB) Income Statement

Standard BioTools reported revenue of $85.33M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 6.2% from $91.01M a year earlier. Standard BioTools posted a net loss of $149.79M, compared with a net loss of $138.88M a year earlier. Gross margin was 49.9% and operating margin -129.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $20.10M, down 7.6% from the same quarter a year earlier.

Standard BioTools Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Standard BioTools Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	85.33	91.01	106.34	97.95	130.58	138.14	117.24	112.96	101.94
Cost of Revenue	42.79	46.13	55.89	60.90	99.15	91.28	52.96	51.32	49.96
Gross Profit	42.54	44.88	50.45	37.05	69.37	46.87	64.28	61.65	51.98
Operating Expenses
Research & Development	25.99	28.83	25.95	37.38	37.94	36.46	31.64	30.03	30.83
Selling, General & Administrative	109.86	103.06	87.54	102.29	98.89	97.90	84.48	79.78	79.52
Operating Expenses	152.79	131.89	127.05	139.67	136.83	97.90	116.12	109.81	110.34
Operating Income	-110.25	-87.01	-76.60	-102.62	-67.46	-51.04	-51.84	-48.16	-58.36
Other Income/Expense
Interest Income	9.18	20.20	5.57	2.23	7.14	0.00	0.00	0.00	0.00
Interest Expense	0.03	3.32	-4.57	4.33	-3.82	-3.57	4.28	13.89	5.82
Other Income/Expense	13.55	-20.27	2.40	-88.21	3.80	0.51	-14.87	-13.26	-5.44
Income
Income Before Tax	-96.70	-90.40	-74.20	-192.93	-63.66	-54.10	-66.71	-61.42	-63.80
Income Tax Expense	-37.88	0.54	0.45	-2.83	-4.42	-1.08	-1.92	-2.41	-3.26
Net Income	-149.79	-138.89	-149.31	-190.10	-59.24	-53.02	-64.79	-59.01	-60.54
Net Income - Continuous Operations	-58.83	-90.94	-74.66	-190.10	-59.24	-53.02	-64.79	-59.01	-60.54
Net Income - Discontinued Operations	-16.07	-47.95	-	-	-	-	-	-	-
EBITDA	-82.33	-70.22	-47.86	-173.57	-63.81	-47.02	-46.62	-31.03	-39.68
EBIT	-93.31	-87.08	-63.04	-188.60	-67.46	-51.04	-	-	-
Depreciation & Amortization	10.98	16.86	15.18	15.03	3.65	4.01	15.81	16.50	18.30
Earnings Per Share
Basic EPS	-	-1.00	-1.00	-2.00	-1.00	-1.00	-1.00	-1.00	-2.00
Diluted EPS	-	-1.00	-1.00	-2.00	-1.00	-1.00	-1.00	-1.00	-2.00
Basic Shares Outstanding	381.62	352.67	79.16	78.31	75.79	72.04	66.78	39.65	32.98
Diluted Shares Outstanding	381.62	352.67	79.16	78.31	75.79	72.04	66.78	39.65	32.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Standard BioTools Financial Statements

What was Standard BioTools's revenue in fiscal 2025?

Standard BioTools reported revenue of $85.33M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 6.2% from $91.01M a year earlier.

Is Standard BioTools profitable?

No. Standard BioTools reported a net loss of $149.79M in fiscal 2025. In fiscal 2024 it lost $138.88M.

What is Standard BioTools's operating margin?

Standard BioTools's operating income was −$110.25M on revenue of $85.33M in fiscal 2025, an operating margin of -129.2%, compared with -95.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition